RECRUITING

Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in Schizophrenia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study how hallucinations work in schizophrenia. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study the investigators will be stimulating the brain to learn more about how TMS might improve these symptoms of schizophrenia.

Official Title

Empirical Validation of a Cerebellar-cortical Hallucination Circuit

Quick Facts

Study Start:2021-10-13
Study Completion:2026-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05343598

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of schizophrenia or schizoaffective disorder
  1. * substance use disorder in past 3 months
  2. * ambidexterity
  3. * contraindications for TMS or MRI including :
  4. * history of neurological disorder
  5. * history of head trauma resulting in loss of consciousness
  6. * history of seizures or diagnosis of epilepsy or first degree relative family history of epilepsy
  7. * metal in brain or skull
  8. * implanted devices such as a pacemaker, medication pump, nerve stimulator or ventriculoperitoneal shunt
  9. * claustrophobic in MRI

Contacts and Locations

Study Contact

Mark Halko, PhD
CONTACT
mhalko@mclean.harvard.edu

Principal Investigator

Mark Halko, PhD
PRINCIPAL_INVESTIGATOR
Mclean Hospital

Study Locations (Sites)

McLean Hospital
Belmont, Massachusetts, 02478
United States

Collaborators and Investigators

Sponsor: Mclean Hospital

  • Mark Halko, PhD, PRINCIPAL_INVESTIGATOR, Mclean Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-10-13
Study Completion Date2026-10-31

Study Record Updates

Study Start Date2021-10-13
Study Completion Date2026-10-31

Terms related to this study

Additional Relevant MeSH Terms

  • Schizophrenia
  • Schizo Affective Disorder